We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Proposed Rule Would Streamline cGMPs for PET Drugs
FDA Proposed Rule Would Streamline cGMPs for PET Drugs
October 3, 2005
The FDA has issued a proposed rule that would streamline cGMPs for the manufacture of positron emission tomography (PET) drugs, making it easier for drug producers to comply with federal quality requirements.